Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34

Mehmet Arif ICER | Health Professions | Young Scientist Award

Published on by Shen Awards

Assist. Prof. Dr. Mehmet Arif ICER | Health Professions | Young Scientist Award

Assistant Professor Doctor from Amasya University, Turkey

Dr. Mehmet Arif İÇER is an Assistant Professor and Head of the Department of Nutrition and Dietetics at Amasya University, Turkey. With a robust academic and research background, he has rapidly ascended into leadership roles within academia, also serving as the Vice Dean of the Faculty of Health Sciences. His academic journey is marked by excellence in nutrition science, with a particular focus on clinical nutrition, nutritional biomarkers, and metabolic health. Dr. İÇER’s research portfolio includes over 28 peer-reviewed articles published in internationally recognized journals, and his work is widely cited, earning him a position among Stanford’s Top 2% Scientists in 2024. He is actively engaged in both teaching and research, contributing to the academic community through book chapters, conference presentations, and interdisciplinary collaborations. His contributions to science have earned him not only national recognition but also growing international attention. Dr. İÇER is known for his deep interest in biochemistry, dietetics, and evidence-based clinical nutrition. His dedication to public health, teaching, and academic excellence makes him a well-rounded and highly respected young scientist in his field. His role as an academic leader and researcher exemplifies a balanced and progressive academic career in health sciences.

Professional Profile

Education

Dr. Mehmet Arif İÇER holds a comprehensive academic background in the field of Nutrition and Dietetics. He completed his Ph.D. at Gazi University in Ankara, Turkey, between 2018 and 2022, where he focused on evaluating the effects of omega-3 supplementation on serum fetuin-A levels in coronary artery disease—an important contribution to cardiovascular nutrition science. His Master of Science degree, also from Gazi University (2016–2018), examined urinary osteopontin levels and nutritional status in patients with kidney stones. These research endeavors demonstrate his early commitment to investigating nutritional biomarkers and clinical outcomes. Dr. İÇER earned his Bachelor of Science in Nutrition and Dietetics from Erciyes University, Kayseri (2009–2014). During his undergraduate studies, he also participated in the Erasmus exchange program at Semmelweis University in Budapest, Hungary, where he gained valuable international academic exposure. His educational trajectory illustrates a strong foundation in evidence-based nutrition science, combining both theoretical knowledge and clinical application. Each academic step has reinforced his expertise in clinical biochemistry, dietetics, and metabolic health. The depth and continuity of his educational background have been instrumental in shaping his current research focus, academic leadership, and instructional responsibilities at Amasya University.

Professional Experience

Dr. Mehmet Arif İÇER has a well-rounded professional career marked by both academic and administrative roles. He began as a Research Assistant at Amasya University in 2014–2015 before moving to Gazi University, where he continued in the same capacity from 2015 to 2022. During this period, he was actively involved in academic teaching, student mentorship, and collaborative research projects that spanned nutrition therapy, dietary biomarkers, and public health. His dedication and expertise earned him a faculty position as Assistant Professor at Amasya University in 2022. He quickly rose to become the Head of the Department of Nutrition and Dietetics and subsequently the Vice Dean of the Faculty of Health Sciences in 2023. These leadership roles reflect his exceptional organizational skills, administrative competence, and ability to drive academic programs forward. Dr. İÇER’s career is characterized by a dual focus on teaching and research, with a strong emphasis on advancing the quality of nutrition education and fostering interdisciplinary collaboration. His experience working in diverse institutional environments, both as a researcher and as an academic leader, positions him as a dynamic professional with the ability to influence health sciences education and research at both national and international levels.

Research Interests

Dr. Mehmet Arif İÇER’s research interests are deeply rooted in the intersection of clinical nutrition, biochemistry, and public health. He focuses on the role of dietary components and nutritional status in chronic diseases such as coronary artery disease, kidney stones, diabetes, and metabolic syndrome. His doctoral research on the impact of omega-3 fatty acids on serum fetuin-A levels highlights his interest in identifying novel biomarkers for disease diagnosis and management. He is also deeply engaged in studies exploring the relationships between diet quality, food neophobia, orthorexia nervosa, and nutritional adequacy. Another significant area of interest includes gut-brain axis modulation via dietary lipids and the implications of antioxidant dietary indexes. Dr. İÇER has contributed to the understanding of how food and nutritional habits, influenced by sociocultural factors, affect metabolic and cardiovascular health. His interdisciplinary approach often integrates elements from genomics, nutritional epidemiology, and behavioral science, aiming to provide comprehensive insights into how diet impacts health. Through collaborations, book chapters, and conference presentations, he extends his expertise to issues such as fermented foods, food labeling, and religious influences on diet. His research is both practical and innovative, targeting real-world health issues with scientific rigor.

Research Skills

Dr. Mehmet Arif İÇER possesses a diverse and advanced set of research skills critical to the field of health and nutrition sciences. His expertise spans clinical trial design, nutritional assessment, biomarker evaluation, and biochemical laboratory analysis. With strong grounding in medical nutrition therapy and clinical biochemistry, he is well-versed in analyzing how dietary interventions affect physiological markers, such as serum fetuin-A and urinary osteopontin. He demonstrates significant ability in scientific writing and interpretation of statistical data, with nearly 30 peer-reviewed publications to his name. His skills in SPSS, research methodology, and critical review enable him to evaluate both clinical and population-level health outcomes effectively. Dr. İÇER also excels in presenting research findings through scientific posters, oral presentations, and lectures. His technical proficiency extends to Microsoft Office tools, with excellent command of Word, Excel, PowerPoint, and Outlook for academic and administrative use. Furthermore, he maintains a strong knowledge base in current health technologies and is continuously updating his research toolkit. His ability to work collaboratively across disciplines and communicate scientific knowledge effectively has contributed to his success in academia. These skills make him a valuable contributor to ongoing advancements in nutrition and health research.

Awards and Honors

Dr. Mehmet Arif İÇER has received significant recognition for his scholarly contributions, the most prominent being his inclusion in the Stanford University Top 2% Scientists List in 2024, an honor that acknowledges his impactful scientific output and citation record. With a total of 980 citations and an h-index of 11, his work demonstrates both quantity and quality in terms of scientific contributions. His publications in respected international journals such as Journal of Clinical Medicine, Food Science & Nutrition, and International Journal of Environmental Health Research further attest to his academic excellence. Dr. İÇER has also contributed several book chapters and presented at numerous national and international scientific conferences. His early involvement in scientific discourse through poster and oral presentations reflects his long-standing commitment to advancing knowledge in dietetics and health sciences. His academic accolades and growing influence underscore his role as a young leader in nutrition science. In recognition of his leadership, he has also been appointed as the Head of Department and Vice Dean at Amasya University. These distinctions not only honor his academic accomplishments but also signal his potential to make enduring contributions to the field of nutrition and public health.

Conclusion

Dr. Mehmet Arif İÇER exemplifies the qualities of an outstanding young academic and researcher in the field of nutrition and health sciences. His career trajectory, from an early-stage researcher to an academic leader, reflects dedication, scholarly rigor, and a strong commitment to improving public health through science. His research contributions span critical areas such as dietary biomarkers, nutritional status, and disease prevention, aligning with global health priorities. With a well-documented record of peer-reviewed publications, international recognition, and teaching experience, Dr. İÇER has carved out a niche as a thought leader in clinical and community nutrition. His administrative roles further demonstrate his leadership abilities and vision for academic excellence. As a recipient of global recognition, including Stanford’s Top 2% Scientists listing, he stands out as a highly promising candidate for any academic or scientific distinction. Dr. İÇER’s dynamic engagement with research, education, and academic service positions him as a role model for emerging scholars in the health sciences. His continued commitment to interdisciplinary research, international collaboration, and innovation will undoubtedly contribute significantly to advancing both science and public well-being.

Publications Top Notes

  1. Title: Involvement of miRNAs in the Cluster of Metabolic Factors of MetS: Nutrition-Genome-MetS Axis
    Journal: Journal of Clinical Medicine
    Year: 2025
    Authors: Duygu Agagündüz, Menşure Nur Çelik, Burcu Deniz Güneş, Büşra Atabilen, Buse Sarıkaya, Mehmet Arif İçer, Ferenc Budán
  2. Title: Association of physical activity status with dietary energy density and nutritional adequacy
    Journal: Food Science and Technology (Brazil)
    Year: 2022
    Authors: Yesildemir, O.; Gencer Bingol, F.; Içer, M.A.; Koksal, E.
  3. Title: Effects of fetuin-A with diverse functions and multiple mechanisms on human health
    Journal: Clinical Biochemistry
    Year: 2021
    Authors: İçer, M.A.; Yıldıran, H.
  4. Title: Effects of vitamin E on neurodegenerative diseases: An update
    Journal: Acta Neurobiologiae Experimentalis
    Year: 2021
    Authors: İçer, M.A.; Arslan, N.; Gezmen-Karadag, M.
  5. Title: Effects of nutritional status on serum fetuin-A level
    Journal: Critical Reviews in Food Science and Nutrition
    Year: 2020
    Authors: İçer, M.A.; Yıldıran, H.
  6. Title: Response to the letter to the editor: Urine osteopontin: A biomarker for diagnosis of nephrolithiasis?
    Journal: Clinical Biochemistry
    Year: 2019
    Authors: İçer, M.A.; Gezmen-Karadag, M.; Sozen, S.
  7. Title: The potential effects of dietary food and beverage intakes on the risk of kidney stone formation
    Journal: Revista de Nutrição
    Year: 2019
    Authors: İçer, M.A.; Gezmen-Karadag, M.
  8. Title: Can urine osteopontin levels, which may be correlated with nutrition intake and body composition, be used as a new biomarker in the diagnosis of nephrolithiasis?
    Journal: Clinical Biochemistry
    Year: 2018
    Authors: İçer, M.A.; Gezmen-Karadag, M.; Sozen, S.
  9. Title: The multiple functions and mechanisms of osteopontin
    Journal: Clinical Biochemistry
    Year: 2018
    Authors: İçer, M.A.; Gezmen-Karadag, M.

Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Heba Jalloun | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Heba Jalloun | Medicine and Dentistry | Best Researcher Award

King Fahd Armed Forces Hospital from Saudi Arabia

Dr. Heba Essam Jalloun is a highly accomplished consultant in colorectal, minimally invasive, and robotic surgery, currently based at King Fahd Armed Forces Hospital (KFAFH) in Jeddah, Saudi Arabia. With over two decades of extensive clinical, academic, and research experience, Dr. Jalloun has demonstrated a steadfast commitment to the advancement of surgical practice, training, and innovation in her field. She earned her Bachelor’s degree in Medicine and Surgery from King Abdul-Aziz University in 2000, followed by the Saudi Specialty Certificate in General Surgery in 2008. Her international training includes two prestigious fellowships in South Korea focusing on minimally invasive, laparoscopic, robotic, oncology, and pelvic floor surgeries. Beyond her clinical responsibilities, she actively participates in training future surgeons as the Director of the General Surgery Saudi Board Residency Program at KFAFH. Dr. Jalloun is widely recognized for her contributions as a speaker at national and international conferences, as well as her active participation in surgical societies across Saudi Arabia, Europe, and Asia. Her work during the COVID-19 pandemic as a frontliner and her extensive involvement in global research collaborations further emphasize her dedication to both patient care and the academic community.

Professional Profile

Education

Dr. Heba Jalloun’s educational foundation is rooted in excellence and international exposure. She began her medical education at King Abdul-Aziz University, where she earned her Bachelor’s degree in Medicine and General Surgery (MBChB) between 1994 and 2000. After passing the Saudi License Exam in 2000, she pursued her residency in General Surgery through the Saudi Board program, completing her Saudi Specialty Certificate in General Surgery (SSC-SURG) in 2008. Her postgraduate training was distinguished by a strong focus on advanced surgical techniques, particularly in minimally invasive procedures. She furthered her expertise through two consecutive fellowships in South Korea: one in Minimal Invasive Surgery, Laparoscopic & Robotic Surgery for Colorectal Diseases (2015–2016), and the second in Oncology, Proctology, and Pelvic Floor Surgery (2017). These fellowships were undertaken at the Catholic University of Korea, Seoul St. Mary’s Hospital, providing her with global perspectives and high-level surgical training. Dr. Jalloun also acquired numerous certifications including ATLS instructor, Basic Surgical Skills instructor, Advanced Cardiac Life Support, and the Train of Trainer (TOT) program. Her dedication to continuous professional development is further evident through her involvement in structured surgical courses and certifications that support both clinical excellence and teaching proficiency.

Professional Experience

Dr. Heba Jalloun’s professional career spans over two decades of dedicated service, with a significant focus on general, colorectal, and robotic surgery. She began her journey in clinical practice as a resident in family medicine from 2001 to 2003, then transitioned into general surgery residency at Northwest Armed Forces Hospital and King Abdulaziz & Oncology Center from 2003 to 2008. After receiving her board certification, she was appointed as a Registrar and later an Assistant Consultant in General Surgery at KFAFH. Her expertise and leadership were recognized as she advanced to the roles of General Surgery Consultant in 2014 and Colorectal, Minimally Invasive, and Robotic Surgery Consultant in 2018. In 2022, she was appointed Director of the Saudi Board General Surgery Residency Program at KFAFH. Alongside clinical duties, Dr. Jalloun has led and organized numerous simulation-based training courses, contributed significantly to resident education, and participated in advanced surgical workshops both nationally and internationally. Her role during the COVID-19 pandemic as a frontliner and key investigator in global surgical research further highlights her dynamic and compassionate leadership. She is also an active member of surgical societies in Saudi Arabia and abroad, bridging international best practices with local healthcare advancements.

Research Interests

Dr. Heba Jalloun’s research interests are aligned closely with her clinical expertise in colorectal surgery, minimally invasive techniques, and oncology. She is deeply engaged in advancing surgical methodologies through evidence-based studies and is particularly focused on Enhanced Recovery After Surgery (ERAS) protocols, outcomes of laparoscopic procedures, and the management of colorectal diseases. Her international collaborations reflect her commitment to global health challenges, especially in the context of the COVID-19 pandemic, where she co-authored several high-impact publications addressing surgical delays, postoperative complications, and vaccine safety related to surgical outcomes. Additionally, she is interested in surgical education, clinical audits, and quality improvement projects—particularly those improving patient discharge efficiency and postoperative recovery. Dr. Jalloun has also explored surgical techniques in emergency abdominal procedures and rare case reports, including drug addiction among high school students. Her current and ongoing research includes hospital-based projects, international multicenter cohort studies, and case series publications. Through this multifaceted research approach, Dr. Jalloun aims to bridge gaps between clinical practice and academic inquiry, ultimately contributing to improved patient safety, surgical precision, and innovation in healthcare systems across the region and globally.

Research Skills

Dr. Heba Jalloun possesses a strong portfolio of research skills encompassing clinical study design, data collection, analysis, publication, and academic presentations. She has served as a principal investigator for several international multicenter studies focused on elective cancer surgery, acute cholecystitis, and surgical outcomes during the COVID-19 pandemic. Her contributions demonstrate proficiency in conducting prospective cohort studies, managing collaborative global datasets, and interpreting clinical implications across diverse healthcare settings. Additionally, Dr. Jalloun is skilled in writing and reviewing scientific manuscripts, poster presentations, and case reports. Her research on ERAS protocols, laparoscopic surgery outcomes, and oncologic safety has been published in respected international journals. She actively contributes to hospital-based quality improvement projects and is proficient in coordinating multidisciplinary research teams. Dr. Jalloun’s training experience also equips her with excellent skills in presenting at international symposiums, conducting workshops, and teaching evidence-based surgical practices. Her ability to integrate research into clinical practice makes her an asset to both academic and medical institutions. Furthermore, her dedication to mentorship and supervision of trainees in research-related tasks reinforces her role as a leader in academic medicine and clinical education.

Awards and Honors

Dr. Heba Jalloun has received multiple awards and honors in recognition of her clinical excellence, teaching capabilities, and service to the healthcare community. She was honored with the Best Instructor and Teacher award at King Fahd Armed Forces Hospital (KFAFH) for the academic year 2019–2020, reflecting her impactful contributions to surgical education. Earlier in her career, she was recognized as the Best Senior Registrar in 2010–2011, showcasing her exceptional performance during residency. Her role as an instructor in ATLS and Basic Surgical Skills courses since 2005 further highlights her longstanding commitment to surgical training. Dr. Jalloun received certificates of appreciation for her contributions to patient safety and experience in both 2021 and 2023, underlining her dedication to improving healthcare quality. During the COVID-19 pandemic, she was acknowledged for her invaluable service as a frontliner and key investigator in international research collaborations. Additionally, she has been commended for her participation as a speaker in numerous national and international symposiums. These accolades collectively reflect her multifaceted contributions as a surgeon, educator, researcher, and leader committed to advancing the field of surgery and patient care at both national and global levels.

Conclusion

In conclusion, Dr. Heba Essam Jalloun exemplifies the qualities of a distinguished surgeon, educator, and researcher, making her a strong candidate for the Best Researcher Award. Her career demonstrates an exceptional balance between clinical practice, academic leadership, and impactful research contributions. Through her international training in advanced surgical techniques and ongoing participation in global collaborative studies, she has significantly enriched both patient outcomes and medical knowledge. Her work during the COVID-19 pandemic, alongside her numerous publications and hospital projects, highlights her commitment to addressing real-world challenges with scientific rigor. Dr. Jalloun’s leadership in surgical education, evident from her role as Director of the Saudi Board Residency Program, further establishes her as a mentor and role model for future generations of surgeons. With multiple awards recognizing her teaching, service, and research, she has shown unwavering dedication to excellence in healthcare. While her work is already commendable, expanding her independent research leadership and engaging in broader interdisciplinary projects could further enhance her impact. Overall, Dr. Jalloun’s credentials and achievements reflect not only her expertise but also her vision for continuous innovation and improvement in surgery and medical education. She is a highly deserving candidate for this prestigious recognition.

Publications Top Notes

  • Title: Influence of the Enhanced Recovery After Surgery Protocol on Postoperative Inflammation and Short-Term Postoperative Surgical Outcomes After Colorectal Cancer Surgery

  • Authors: Jalloun Heba Essam (H.E.), Lee In Kyu (I.K.), Kim Min-ki (M.), Lee Yoon-suk (Y.), Jeon Hae-myung (H.)

  • Year: 2020

  • Citations: 19

Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Published on by Shen Awards

Prof. Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Prof Tehran university of medical sciences at Iran

Dr. Marjan Ghaemi is an accomplished gynecologist, obstetrician, and infertility specialist with a fellowship in endocrinology. She serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, Tehran University of Medical Sciences. With a strong background in both clinical and research fields, she has dedicated her career to advancing reproductive health. Her expertise spans infertility treatments, reproductive endocrinology, gynecological oncology, and minimally invasive surgery. Additionally, she has played a significant role in medical research and education, holding editorial positions in esteemed journals. Dr. Ghaemi has also contributed to digital health innovations, developing medical IT solutions and e-learning programs. With extensive experience in clinical research, trial management, and evidence-based medicine, she has been instrumental in improving reproductive healthcare. Her leadership in both academia and clinical practice has positioned her as a key figure in the field. Passionate about bridging the gap between research and patient care, she continues to explore new frontiers in reproductive medicine. Her contributions to gynecology and infertility research make her a strong contender for prestigious awards. She strives to integrate cutting-edge technology and medical advancements to enhance women’s healthcare, both nationally and internationally.

Professional Profile

Education

Dr. Marjan Ghaemi has an extensive educational background in medicine, gynecology, and reproductive endocrinology. She obtained her Doctorate in Medicine (MD) from Tehran University of Medical Sciences (TUMS), where she conducted research on the prevalence of polycystic ovary syndrome (PCOS) in adolescents. She further pursued specialization in obstetrics and gynecology at TUMS, achieving the highest national board exam score in OB/GYN in 2019. Her residency research focused on evaluating the quality of life in gynecological cancer patients using a web-based study. Dr. Ghaemi then completed a fellowship in infertility and endocrinology at TUMS, where she conducted a randomized controlled trial comparing different ovarian stimulation protocols in IVF patients with PCOS. Her educational achievements reflect her strong academic foundation and commitment to evidence-based medicine. With a focus on reproductive endocrinology, infertility treatments, and gynecological oncology, her research and clinical training have positioned her as a leader in her field. Her education not only provided her with deep clinical expertise but also honed her research skills, allowing her to contribute significantly to scientific advancements. Through her academic journey, she has consistently demonstrated excellence in both research and patient care, making significant contributions to reproductive medicine.

Professional Experience

Dr. Marjan Ghaemi has a distinguished professional career in clinical practice, academia, and research. She currently serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, TUMS, where she focuses on infertility treatments and reproductive endocrinology. She previously worked as an Assistant Professor at Kamali Hospital, Alborz University of Medical Sciences. Her expertise includes advanced infertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and minimally invasive gynecological surgeries. Dr. Ghaemi has also played a significant role in scientific publishing, serving as the Chief Editor of Fertility, Gynecology and Andrology and as an Associate Editor for the Journal of Family and Reproductive Health. Her research leadership extends to clinical trials and medical IT innovations. As a Clinical Research Manager at Farzan Clinical Research, she supervised multiple Phase II-IV studies and contributed to the development of digital health solutions, including e-learning platforms and medical applications. She has also worked extensively in hospital settings, managing complex cases in gynecology, obstetrics, and infertility. Her vast experience in research, patient care, and medical education makes her a well-rounded professional dedicated to advancing women’s health and reproductive medicine.

Research Interests

Dr. Marjan Ghaemi’s research focuses on reproductive endocrinology, infertility, and gynecological health. She has a particular interest in polycystic ovary syndrome (PCOS), exploring its prevalence, impact on fertility, and treatment options. Her work in in-vitro fertilization (IVF) has contributed to optimizing ovarian stimulation protocols, improving success rates for women with infertility. She is also interested in recurrent pregnancy loss and male infertility, expanding her research to encompass both partners in reproductive challenges. Additionally, Dr. Ghaemi has investigated the quality of life in gynecological cancer patients, seeking ways to enhance supportive care. Her research extends to hormonal therapies, reproductive surgeries, and minimally invasive techniques, contributing to advancements in assisted reproductive technology (ART). Another key area of her work involves the integration of digital health in reproductive medicine, including e-learning platforms and telemedicine for patient education. She is passionate about bridging the gap between clinical practice and research, ensuring that scientific advancements translate into better patient outcomes. Her multidisciplinary approach combines clinical expertise with innovative research methodologies, making her a leader in reproductive medicine. Through her studies, she aims to improve fertility treatments and reproductive health care, benefiting both patients and the scientific community.

Research Skills

Dr. Marjan Ghaemi possesses advanced research skills in clinical trials, reproductive endocrinology, and gynecological health. She is proficient in designing and conducting randomized controlled trials (RCTs), as demonstrated in her research on ovarian stimulation protocols in IVF. She has extensive experience in medical research methodologies, data analysis, and evidence-based practice. Her expertise in site monitoring, project management, and medical reporting has made her a key contributor to clinical research studies. Additionally, she has strong skills in digital health and medical IT, having developed e-learning platforms, mobile health applications, and smart e-health projects. Dr. Ghaemi’s editorial roles in leading medical journals have enhanced her abilities in scientific publishing, peer review, and manuscript editing. She is also skilled in medical writing and literature reviews, ensuring high-quality contributions to academic publications. Her experience in biostatistics and research ethics allows her to conduct rigorous and ethically sound studies. Furthermore, she has expertise in advanced imaging techniques such as gynecological and infertility ultrasound, enhancing her research capabilities in diagnostic medicine. Her diverse skill set in clinical and digital research makes her a valuable figure in reproductive medicine, contributing to scientific advancements and improved patient care.

Awards and Honors

Dr. Marjan Ghaemi has received several awards and honors in recognition of her academic excellence and contributions to reproductive medicine. She achieved the highest national board exam score in OB/GYN in 2019, demonstrating her outstanding medical knowledge and expertise. Her research on polycystic ovary syndrome (PCOS) and infertility treatments has been acknowledged in various academic and clinical circles. She has also played a pivotal role in medical research and journal editing, earning recognition for her editorial leadership in Fertility, Gynecology and Andrology and Journal of Family and Reproductive Health. As a Clinical Research Manager at Farzan Clinical Research, she was part of a team that earned national recognition as a top knowledge-based institute. Additionally, her contributions to medical IT and e-learning have been praised, as she has led projects in digital health solutions for reproductive medicine. Her work in gynecological cancer quality-of-life studies has also been highlighted in medical research communities. With her achievements in academia, research, and digital innovation, Dr. Ghaemi continues to be recognized as a leading figure in reproductive health and infertility research, making significant contributions to the field.

Conclusion

Dr. Marjan Ghaemi is an exceptional researcher and clinician in reproductive medicine, with expertise spanning gynecology, infertility, and endocrinology. Her contributions to clinical research, medical education, and digital health innovation have positioned her as a leader in the field. With a strong academic background, she has conducted impactful research on PCOS, IVF, and gynecological health, improving fertility treatment outcomes. Her editorial roles in leading journals further emphasize her dedication to advancing scientific knowledge. She has also played a key role in integrating digital health solutions into reproductive medicine, enhancing patient education and research methodologies. While she has achieved significant milestones, expanding her international collaborations and high-impact publications could further elevate her global presence. Overall, her dedication to evidence-based medicine and patient-centered care makes her a strong candidate for prestigious research awards. Dr. Ghaemi’s work is instrumental in shaping the future of reproductive health, and she remains committed to pioneering advancements in infertility treatments and women’s healthcare. With her expertise, leadership, and passion for research, she continues to make remarkable contributions to medical science and patient well-being.

Publications Top Notes

  1. Title: Uterus transplantation: A bibliometric review of six-decade study from 1960 to 2024
    Authors: R. Akbari, M. Ghaemi, Z.Y. Panahi
    Year: 2025
    Citations: 1

  2. Title: The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis
    Authors: A.M. Tarafdari, F. Keikha, F. Asadi, M. Forouzin, M. Ghaemi
    Year: 2024

  3. Title: Knowledge, attitudes, and practices of healthcare providers among women oncofertility in Iran: a cross-sectional study
    Authors: M. Ghaemi, I. Rokhzadi, M. Dashtkoohi, N. Eshraghi, M. Fakehi
    Year: 2024

  4. Title: Potential efficacy of digital polymerase chain reaction for non-invasive prenatal screening of autosomal aneuploidies: a systematic review and meta-analysis
    Authors: M. Parsaei, M. Dashtkoohi, T. Salmani, M. Ghaemi, S. Hantoushzadeh
    Year: 2024

  5. Title: The association between increased fetal movements in the third trimester and perinatal outcomes; a systematic review and meta-analysis
    Authors: S. Hantoushzadeh, O. Kohandel Gargari, M. Jamali, Z. Panahi, G.R. Habibi
    Year: 2024

  6. Title: Breast Implant Illness as a Challenging Disorder in Clinics
    Authors: F.G. Vahdani, M. Ghaemi, M. Haddadi
    Year: 2024

  7. Title: The association between the amount of fetal fraction in cell-free DNA testing and adverse pregnancy outcomes: A cohort study
    Authors: M. Aryavand, M. Noorzadeh, M. Ghaemi, S.E. Delfan, V. Marsoosi
    Year: 2024

  8. Title: Analysis of medico-legal claims related to deliveries: Caesarean section vs. vaginal delivery
    Authors: N. Eshraghi, M. Ghaemi, Z. Shabannejad, Z. Mansouri, S. Hantoushzadeh
    Year: 2024
    Citations: 1

  9. Title: The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis
    Authors: M. Ghaemi, N. Seighali, A. Shafiee, Z.Y. Panahi, S. Hantoushzadeh
    Year: 2024
    Citations: 1